Investors with a lot of money to spend have taken a bullish stance on AstraZeneca AZN.
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don’t know. But when something this big happens with AZN, it often means somebody knows something is about to happen.
Today, Benzinga’s options scanner spotted 9 options trades for AstraZeneca.
This isn’t normal.
The overall sentiment of these big-money traders is split between 55% bullish and 44%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $33,835, and 8, calls, for a total amount of $3,881,635.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it’s evident that the major market movers are focusing on a price band between $65.0 and $77.5 for AstraZeneca, spanning the last three months.
Analyzing Volume & Open Interest
In today’s trading context, the average open interest for options of AstraZeneca stands at 1003.75, with a total volume reaching 7,809.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AstraZeneca, situated within the strike price corridor from $65.0 to $77.5, throughout the last 30 days.
AstraZeneca Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AZN | CALL | TRADE | BULLISH | 01/16/26 | $5.9 | $5.55 | $5.8 | $77.50 | $1.9M | 3.1K | 0 |
| AZN | CALL | TRADE | BEARISH | 06/20/25 | $3.3 | $3.15 | $3.2 | $75.00 | $1.0M | 2.4K | 3.5K |
| AZN | CALL | TRADE | BULLISH | 06/20/25 | $2.34 | $2.0 | $2.3 | $77.50 | $689.9K | 535 | 3.0K |
| AZN | CALL | SWEEP | BEARISH | 04/17/25 | $8.2 | $8.15 | $8.15 | $65.00 | $39.1K | 920 | 368 |
| AZN | CALL | SWEEP | BULLISH | 04/17/25 | $8.0 | $7.8 | $8.0 | $65.00 | $38.3K | 920 | 740 |
About AstraZeneca
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
Having examined the options trading patterns of AstraZeneca, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is AstraZeneca Standing Right Now?
- Trading volume stands at 4,149,033, with AZN’s price up by 0.87%, positioned at $72.61.
- RSI indicators show the stock to be may be overbought.
- Earnings announcement expected in 73 days.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AstraZeneca, Benzinga Pro gives you real-time options trades alerts.
Overview Rating:
Speculative
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
